Tianshui Zhongxing Bio-technology Co Ltd (002772) - Total Liabilities
Based on the latest financial reports, Tianshui Zhongxing Bio-technology Co Ltd (002772) has total liabilities worth CN¥4.18 Billion CNY (≈ $611.51 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002772 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Tianshui Zhongxing Bio-technology Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Tianshui Zhongxing Bio-technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 002772 total asset value.
Tianshui Zhongxing Bio-technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tianshui Zhongxing Bio-technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hapvida Participações e Investimentos S.A.
SA:HAPV3
|
Brazil | R$24.74 Billion |
|
Puyang Refractories Group Co Ltd
SHE:002225
|
China | CN¥4.98 Billion |
|
Cars.com Inc
NYSE:CARS
|
USA | $568.83 Million |
|
Anhui Province Natural Gas Development Co Ltd
SHG:603689
|
China | CN¥3.61 Billion |
|
Adcock Ingram Holdings Limited
JSE:AIP
|
South Africa | ZAC2.90 Billion |
|
Lotus Technology Inc.
NASDAQ:LOT
|
USA | $3.23 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$732.53 Million |
|
Ricegrowers Ltd
AU:SGLLV
|
Australia | AU$646.47 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Tianshui Zhongxing Bio-technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 002772 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tianshui Zhongxing Bio-technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tianshui Zhongxing Bio-technology Co Ltd (2011–2025)
The table below shows the annual total liabilities of Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.43 Billion ≈ $502.51 Million |
+19.56% |
| 2024-12-31 | CN¥2.87 Billion ≈ $420.29 Million |
+8.87% |
| 2023-12-31 | CN¥2.64 Billion ≈ $386.06 Million |
-17.15% |
| 2022-12-31 | CN¥3.18 Billion ≈ $465.99 Million |
-3.51% |
| 2021-12-31 | CN¥3.30 Billion ≈ $482.92 Million |
+15.81% |
| 2020-12-31 | CN¥2.85 Billion ≈ $416.99 Million |
+18.20% |
| 2019-12-31 | CN¥2.41 Billion ≈ $352.77 Million |
+63.24% |
| 2018-12-31 | CN¥1.48 Billion ≈ $216.11 Million |
+1.38% |
| 2017-12-31 | CN¥1.46 Billion ≈ $213.18 Million |
+57.99% |
| 2016-12-31 | CN¥922.12 Million ≈ $134.94 Million |
+43.01% |
| 2015-12-31 | CN¥644.80 Million ≈ $94.36 Million |
+14.51% |
| 2014-12-31 | CN¥563.09 Million ≈ $82.40 Million |
+44.18% |
| 2013-12-31 | CN¥390.55 Million ≈ $57.15 Million |
+87.39% |
| 2012-12-31 | CN¥208.41 Million ≈ $30.50 Million |
+83.26% |
| 2011-12-31 | CN¥113.73 Million ≈ $16.64 Million |
-- |
About Tianshui Zhongxing Bio-technology Co Ltd
Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production and sales of edible mushrooms in China and internationally. It offers enoki and button mushrooms; cordyceps militaris; and cordyceps sinensis. The company also engages in agriculture planting, investment management, and real estate development businesses. Tianshui Zhongx… Read more